Zevra Therapeutics Inc. (ZVRA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Zevra Therapeutics Inc.

NASDAQ: ZVRA · Real-Time Price · USD
9.75
0.44 (4.73%)
At close: Oct 03, 2025, 3:59 PM
9.75
0.00%
After-hours: Oct 03, 2025, 07:54 PM EDT

Zevra Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
33.78M 43.05M 65.47M 112.35M
Short-Term Investments
35.71M 24.69M 17.38M n/a
Long-Term Investments
6.01M n/a 20M 15.42M
Other Long-Term Assets
11.38M 9.94M 724K 438K
Receivables
10.51M 17.38M 8.3M 1.53M
Inventory
1.97M 24.08M n/a n/a
Other Current Assets
3.02M -23.43M 189K 252K
Total Current Assets
86.03M 86.94M 93.02M 115.06M
Property-Plant & Equipment
1.01M 1.53M 1.78M 2.02M
Goodwill & Intangibles
73.69M 73.93M n/a n/a
Total Long-Term Assets
92.1M 85.39M 22.51M 17.89M
Total Assets
178.13M 172.33M 115.53M 132.94M
Account Payables
13.07M 13.99M 3.61M 516K
Deferred Revenue
n/a n/a 4.66M 2.52M
Short-Term Debt
n/a 37.7M 486K 371K
Other Current Liabilities
3.2M 10.82M 233K -604K
Total Current Liabilities
34.06M 73.72M 12.02M 4.23M
Long-Term Debt
59.5M 5.07M 12.8M n/a
Other Long-Term Liabilities
44.52M 31.22M 14.55M 355K
Total Long-Term Liabilities
104.4M 36.74M 28.2M 1.59M
Total Liabilities
138.46M 110.46M 40.22M 5.82M
Total Debt
60.3M 43.77M 14.12M 1.61M
Book Value
39.67M 61.86M 75.31M 127.12M
Book Value Per Share
0.86 1.74 2.18 4.27
Common Stock
5K 4K 3K 4K
Retained Earnings
-505.29M -399.78M -353.73M -267.03M
Comprehensive Income
631K -43K 113K n/a
Shareholders Equity
39.67M 61.86M 75.12M 127.12M
Total Investments
41.72M 24.69M 37.38M 15.42M